Your browser doesn't support javascript.
loading
Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.
Barbaret, Cécile; Delgado-Guay, Marvin O; Sanchez, Stéphane; Brosse, Christelle; Ruer, Murielle; Rhondali, Wadih; Monsarrat, Léa; Michaud, Patrick; Schott, Anne Marie; Bruera, Eduardo; Filbet, Marilène.
Afiliação
  • Barbaret C; Department of Supportive and Palliative Care, Centre Hospitalo-Universitaire de Grenoble, La Tronche, France cbarbaret@chu-grenoble.fr.
  • Delgado-Guay MO; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
  • Sanchez S; Department of Medical Information, Evaluation and Performance, Hôpitaux Champagne Sud, Troyes, France.
  • Brosse C; Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.
  • Ruer M; Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.
  • Rhondali W; Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.
  • Monsarrat L; Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.
  • Michaud P; Department of Palliative Care, Institut de Cancérologie de la Loire, Saint-Etienne, France.
  • Schott AM; Pôle IMER, Hospices Civils de Lyon, Lyon, France.
  • Bruera E; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
  • Filbet M; Department of Supportive and Palliative Care, Centre Hospitalier Lyon-Sud, Lyon, France.
Oncologist ; 24(8): 1121-1127, 2019 08.
Article em En | MEDLINE | ID: mdl-30877191
ABSTRACT

BACKGROUND:

Financial distress (FD) is common among patients with advanced cancer. Our purpose was to compare the frequency and intensity of FD and its associations with symptom distress and quality of life (QOL) in these patients in France and the U.S. MATERIALS AND

METHODS:

In this secondary analysis of two cross-sectional studies, we assessed data on 292 patients who received cancer care at a public hospital or a comprehensive cancer center in France (143 patients) or the U.S. (149 patients). Outpatients and hospitalized patients over 18 years of age with advanced lung or breast or colorectal or prostate cancer were included. Diagnosed cognitive disorder was considered a noninclusion criterion. Advanced cancer included relapse or metastasis or locally advanced cancer or at least a second-line chemotherapy regimen. Patients self-rated FD and assessed symptoms, psychosocial distress, and QOL on validated questionnaires.

RESULTS:

The average patient age was 59 years, and 144 (49%) were female. FD and high intensity were reported more frequently in U.S. patients than in French (respectively 129 [88%] vs. 74 [52%], p < .001; 100 [98%] vs. 48 [34%], p < .001,). QOL was rated higher by the U.S. patients than by the French (69 [SD, 18] vs. 63 [SD, 18], p = .003). French patients had more psychological symptoms such as anxiety (8 [SD, 4] vs. 6 [SD, 5], p = .008). Associations were found between FD and U.S. residence, FD and single status (0.907, p = .023), and FD and metastasis (1.538, p = .036). In contrast, negative associations were found between FD and older age (-0.052, p = .003) and FD and France residence (-3.376, p = .001).

CONCLUSION:

Regardless of health care system, FD is frequent in patients with advanced cancer. U.S. patients were more likely to have FD than French patients but reported better QOL. Further research should focus on factors contributing to FD and opportunities for remediation. IMPLICATIONS FOR PRACTICE Suffering is experienced in any component of the lives of patients with a life-threatening illness. Financial distress (FD) is one of the least explored cancer-related symptoms, and there are limited studies describing its impact on this frail population. This study highlights the high frequency and severity of FD in patients with advanced cancer in the U.S. and France as well as its impact on their physical and emotional symptoms and their quality of life in these different health care systems. It is necessary for all health care providers to explore and evaluate the presence of FD in patients living with life-threatening illnesses.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Comparação Transcultural / Efeitos Psicossociais da Doença / Disparidades nos Níveis de Saúde / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies País/Região como assunto: America do norte / Europa Idioma: En Revista: Oncologist Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Comparação Transcultural / Efeitos Psicossociais da Doença / Disparidades nos Níveis de Saúde / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies País/Região como assunto: America do norte / Europa Idioma: En Revista: Oncologist Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França